Prediction. Intel Has Run 492% and Its Own Insiders Are Selling

Photo of Alex Sirois
By Alex Sirois Published
Prediction. Intel Has Run 492% and Its Own Insiders Are Selling

© 24/7 Wall St

At $121.77, Intel (NASDAQ:INTC | INTC Price Prediction) is a Hold. After a year that turned a left-for-dead semiconductor name into one of the market’s loudest comeback stories, the question is whether the price already assumes the turnaround goes perfectly.

Intel designs and manufactures CPUs across three segments: Client Computing, Data Center and AI, and Intel Foundry. Under CEO Lip-Bu Tan, the company has pivoted from survival to capacity constraints, positioning itself as the Western alternative to Asian foundries while reaccelerating its server CPU franchise.

The stock has roughly sextupled from $20.55 a year ago, fueled by aggressive cost cuts, a $5 billion NVIDIA (NASDAQ:NVDA) equity tie-up, a long-term Google (NASDAQ:GOOGL) ASIC deal, and Intel 18A reaching high-volume manufacturing.

Why the bulls think $121 is still early

Q1 FY26 was the sixth consecutive quarter exceeding expectations. Non-GAAP EPS came in at $0.29 against a $0.01 estimate on revenue of $13.58 billion, up 7.18% year over year. Data Center and AI revenue rose 22% and Foundry grew 16%.

Bulls point to structural CPU demand. Tan said the CPU-to-GPU ratio is “moving back towards CPU” as inference and agentic workloads scale, with AI-driven businesses already 60% of revenue and growing 40% year over year. The PEG ratio of 0.501 and Xeon 6 win inside NVIDIA’s DGX Rubin NVL8 systems argue the multiple is forward-looking and reasonable.

Why bears say the math no longer works

Intel posted a $3.73 billion GAAP net loss on a $4.07 billion restructuring charge, free cash flow was negative $3.87 billion, and Intel Foundry lost $2.4 billion in the quarter. Trailing EPS sits at negative $0.60 and forward earnings carry a 149x multiple.

Insiders aren’t adding. The Chief Legal Officer sold at $99.526 and a Foundry EVP sold at $93.6, with no open-market executive buying in the dataset. Management flagged PC unit TAM down a low double-digit % in the second half and rising memory and substrate costs squeezing margins.

The case for patience

Intel 18A is ramping, Q2 guidance calls for revenue of $13.8 billion to $14.8 billion, and the ASIC business is already at a run rate north of $1 billion. Yet Intel 14A could pause if customer demand disappoints, and Foundry GAAP profitability remains theoretical. Let the stock prove the model before adding at six times last year’s price.

What the data says about the gap

INTC trades at $121.77 against a consensus target of $87.86, implying -27.85% downside. Of 48 analysts tracked, 2 rate it Strong Buy, 11 Buy, 30 Hold, 2 Sell, and 3 Strong Sell. A 6-to-1 Hold-to-Buy skew is a clear caution flag.

Shares are up 230% year to date and 492.55% over the past year, while the S&P 500 (proxied by the SPDR S&P 500 ETF Trust (NYSEARCA:SPY)) has moved from $713.94 to $750.46 since the April earnings filing. Forward P/E sits at 149x, price-to-sales at 11.55, and beta at 2.19.

The verdict on $121 Intel

At $121.77, Intel is a Hold.

The turnaround is real. Six straight beats, 41.0% non-GAAP gross margin, and a CPU franchise reasserting relevance inside AI build-outs reflect genuine operating progress. But the equity now prices that outcome as the base case, leaving little room for execution stumbles that semiconductor manufacturing routinely produces.

Upgrade to Buy conditions: sustained GAAP operating income at Intel Foundry, free cash flow turning positive on a trailing basis, and Intel 14A securing announced external customers. Downgrade to Sell conditions: a guide-down on Q3 revenue, an 18A yield walk-back, or any signal that Intel 14A pauses.

The cost of patience is small when consensus already implies 28% downside and insiders are selling into strength. The cost of chasing at $121 is paying full price for a foundry business that has yet to deliver a GAAP profit. Letting gains consolidate while the operating model proves itself is the right call at this price.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

MRNA Vol: 12,447,970
GEV Vol: 3,996,018
WDC Vol: 13,569,058
AMAT Vol: 11,045,394
AVGO Vol: 40,015,334

Top Losing Stocks

KMX Vol: 9,636,234
CTRA Vol: 73,319,495
EFX Vol: 2,027,377
CHTR Vol: 3,521,410
NDAQ Vol: 8,563,965